Cargando…
Anticoagulants as Potential SARS-CoV-2 M(pro) Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR Studies
In this article, 34 anticoagulant drugs were screened in silico against the main protease (M(pro)) of SARS-CoV-2 using molecular docking tools. Idraparinux, fondaparinux, eptifibatide, heparin, and ticagrelor demonstrated the highest binding affinities towards SARS-CoV-2 M(pro). A molecular dynamics...
Autores principales: | Abo Elmaaty, Ayman, Eldehna, Wagdy M., Khattab, Muhammad, Kutkat, Omnia, Alnajjar, Radwan, El-Taweel, Ahmed N., Al-Rashood, Sara T., Abourehab, Mohammed A. S., Binjubair, Faizah A., Saleh, Mohamed A., Belal, Amany, Al-Karmalawy, Ahmed A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603561/ https://www.ncbi.nlm.nih.gov/pubmed/36293094 http://dx.doi.org/10.3390/ijms232012235 |
Ejemplares similares
-
Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro, molecular docking, molecular dynamics, and SAR studies
por: Farouk, Faten, et al.
Publicado: (2023) -
Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N-(5-nitrothiazol-2-yl)-carboxamido candidates: in vitro and in silico studies
por: Al-Karmalawy, Ahmed A., et al.
Publicado: (2023) -
Revisiting activity of some glucocorticoids as a potential inhibitor of SARS-CoV-2 main protease: theoretical study
por: Elmaaty, Ayman Abo, et al.
Publicado: (2021) -
Investigating the Potential Anti-SARS-CoV-2 and Anti-MERS-CoV Activities of Yellow Necklacepod among Three Selected Medicinal Plants: Extraction, Isolation, Identification, In Vitro, Modes of Action, and Molecular Docking Studies
por: Abd-Alla, Howaida I., et al.
Publicado: (2022) -
Molecular docking, molecular dynamics, and in vitro studies reveal the potential of angiotensin II receptor blockers to inhibit the COVID-19 main protease
por: Alnajjar, Radwan, et al.
Publicado: (2020)